The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
Clinical trial NCT03210259 · COMPLETED
Trial details
- NCT number
- NCT03210259
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2019-04-16
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.